ResMed's revenue gets wake up with new products

By Jessica Gardner
Updated October 25 2014 - 8:13am, first published October 24 2014 - 5:07pm
“We are delivering on our promise to drive top-line revenue growth this fiscal year by launching a strong portfolio of new products, services, and solutions.”: ResMed CEO Mick Farrell. Photo: Luis Ascui
“We are delivering on our promise to drive top-line revenue growth this fiscal year by launching a strong portfolio of new products, services, and solutions.”: ResMed CEO Mick Farrell. Photo: Luis Ascui
“We are delivering on our promise to drive top-line revenue growth this fiscal year by launching a strong portfolio of new products, services, and solutions.”: ResMed CEO Mick Farrell. Photo: Luis Ascui
“We are delivering on our promise to drive top-line revenue growth this fiscal year by launching a strong portfolio of new products, services, and solutions.”: ResMed CEO Mick Farrell. Photo: Luis Ascui
“We are delivering on our promise to drive top-line revenue growth this fiscal year by launching a strong portfolio of new products, services, and solutions.”: ResMed CEO Mick Farrell. Photo: Luis Ascui
“We are delivering on our promise to drive top-line revenue growth this fiscal year by launching a strong portfolio of new products, services, and solutions.”: ResMed CEO Mick Farrell. Photo: Luis Ascui

New products used in the treatment sleep disordered breathing, which is associated with snoring, lifted  ResMed's sales in the first quarter.

Get the latest Mandurah news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.